Journal of Viral Hepatitis

Cover image for Vol. 20 Issue 11

November 2013

Volume 20, Issue 11

Pages 745–820

  1. REVIEW

    1. Top of page
    2. REVIEW
    3. ORIGINAL ARTICLES
    1. You have full text access to this OnlineOpen article
      The new paradigm of hepatitis C therapy: integration of oral therapies into best practices (pages 745–760)

      N. H. Afdhal, S. Zeuzem, R. T. Schooley, D. L. Thomas, J. W. Ward, A. H. Litwin, H. Razavi, L. Castera, T. Poynard, A. Muir, S. H. Mehta, L. Dee, C. Graham, D. R. Church, A. H. Talal, M. S. Sulkowski, I. M. Jacobson and for the New Paradigm of HCV Therapy Meeting Participants

      Version of Record online: 7 OCT 2013 | DOI: 10.1111/jvh.12173

      • image
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW
    3. ORIGINAL ARTICLES
    1. Role of hepatitis C virus substitutions and interleukin-28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response-guided therapy (pages 761–769)

      C.-M. Liang, T.-H. Hu, S.-N. Lu, C.-H. Hung, C.-M. Huang, J.-H. Wang, Y.-H. Yen, C.-H. Chen, K.-C. Chang, M.-C. Tsai, Y.-H. Kuo and C.-M. Lee

      Version of Record online: 7 APR 2013 | DOI: 10.1111/jvh.12097

      • image
      • image
    2. Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor (pages 779–789)

      J. de Bruijne, X. V. Thomas, S. P. Rebers, C. J. Weegink, M. A. Treitel, E. Hughes, J. F. Bergmann, R. J. de Knegt, H. L. A. Janssen, H. W. Reesink, R. Molenkamp and J. Schinkel

      Version of Record online: 27 JUN 2013 | DOI: 10.1111/jvh.12104

      • image
      • image
      • image
    3. Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis (pages 790–800)

      V. Di Marco, L. Covolo, V. Calvaruso, M. Levrero, M. Puoti, F. Suter, G. B. Gaeta, C. Ferrari, G. Raimondo, G. Fattovich, T. Santantonio, A. Alberti, R. Bruno, C. Mussini, M. Mondelli, F. Donato, A. Craxì and on behalf of the Multicenter Italian Group for the Study of Hepatitis C

      Version of Record online: 15 SEP 2013 | DOI: 10.1111/jvh.12106

      • image
      • image
    4. You have full text access to this OnlineOpen article
      Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a ‘real-world’ clinical practice setting in China (pages 811–820)

      J.-L. Hou, J.-D. Jia, L. Wei, W. Zhao, Y. M. Wang, M. Cheng, X. Tang, D.-M. Tan, H. Ren, H. Tang, D. Cohen and C. Llamoso

      Version of Record online: 29 MAY 2013 | DOI: 10.1111/jvh.12115

      • image
      • image
      • image

SEARCH

SEARCH BY CITATION